Component manufacturer Analogic reported record revenue of $29.76 million for the year (ended July 31), compared with $27.96 million a year ago. But the company had a drop in net income for the year of $14.1 million, compared with $19.5 million a year
Component manufacturer Analogic reported record revenue of $29.76 million for the year (ended July 31), compared with $27.96 million a year ago. But the company had a drop in net income for the year of $14.1 million, compared with $19.5 million a year earlier.
Analogic's fourth quarter numbers, however, showed a profit of $5.4 million, compared with $3.9 million for the same quarter a year earlier.
"The solid growth demonstrated in our record fourth quarter was due to increased shipments of both medical and industrial products," said Bernard M. Gordon, Analogic's CEO.
The company ships digital radiography systems, ultrasound engines, and connectivity devices, as well as complete ultrasound and CT scanners, to domestic and foreign companies that attach their own labels, said Tom Miller, president and COO.
"We're at the front end and the tail end of systems such as Kodak's DR products (SCAN 10/25/00)," Miller said.
All commercial selenium x-ray plates are coated by Anrad, a wholly owned Analogic subsidiary, he said. These are then supplied to Hologic/DRC, which completes the electronics for plates. Analogic purchases the plates and integrates them with Fischer Imaging components such as generators and table stands, and sells the finished product to Kodak.
Analogic does not really compete with other companies, Miller said, but rather with the R&D sections of the OEMs. It must be able to supply them with high-end products that are better than the ones they could have manufactured themselves.
Miller would not identify Analogic's other OEM customers.
"They want to stick the Made in Japan' or Made in Germany' or Made in Milwaukee' labels on them, so we'll let them identify themselves if they want to," he said.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.